Clearstead Trust, LLC Merck & Co., Inc. Transaction History

Clearstead Trust, LLC

$372 Million
Q3 2024

A detailed history of Clearstead Trust, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Clearstead Trust, LLC holds 27,523 shares of MRK stock, worth $2.74 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

27,523

Previous 28,247 2.56%

Holding current value

$2.74 Million

Previous $3.5 Million 10.61%

% of portfolio

0.84%

Previous 0.97%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $80,472 - $93,374	-724 Reduced 2.56%	27,523 $3.13 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $91,116 - $97,858	-736 Reduced 2.54%	28,247 $3.5 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $282,647 - $329,347	-2,496 Reduced 7.93%	28,983 $3.82 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $116,208 - $126,463	-1,160 Reduced 3.55%	31,479 $3.43 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $53,019 - $58,879	515 Added 1.6%	32,639 $3.36 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $180,509 - $196,747	1,662 Added 5.46%	32,124 $3.71 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $147,821 - $164,938	-1,436 Reduced 4.5%	30,462 $3.24 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $34,888 - $44,731	399 Added 1.27%	31,898 $3.54 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $2.48 Million - $2.78 Million	29,287 Added 1324.01%	31,499 $2.71 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $11,173 - $12,524	-152 Reduced 6.43%	2,212 $181,000
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $86,159 - $94,753	1,202 Added 103.44%	2,364 $178,000
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $81,700 - $90,368	1,162 New	1,162 $90,000
Q1 2021 Apr 30, 2021	SELL	$68.86 - $81.11 $82,632 - $97,332	-1,200 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$73.18 - $82.95 $2,780 - $3,152	38 Added 3.27%	1,200 $100,000
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $2,090 - $2,898	-33 Reduced 2.76%	1,162 $89,000
Q4 2019 Feb 03, 2020	BUY	$77.58 - $87.54 $77 - $87	1 Added 0.08%	1,195 $109,000
Q2 2019 Jul 31, 2019	BUY	$69.84 - $81.59 $2,234 - $2,610	32 Added 2.75%	1,194 $0
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $28,736 - $32,775	-413 Reduced 26.22%	1,162 $97,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $42,145 - $48,908	-646 Reduced 29.09%	1,575 $114,000
Q3 2018 Nov 15, 2018	BUY	$57.69 - $67.84 $7,788 - $9,158	135 Added 6.47%	2,221 $158,000
Q2 2018 Aug 20, 2018	BUY	$50.83 - $59.72 $106,031 - $124,575	2,086 New	2,086 $127,000
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $224,478 - $260,908	-4,405 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	4,405	4,405 $282,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.

Account

Clearstead Trust, LLC Merck & Co., Inc. Transaction History